Kempen International Funds et al v. Syneos Health Inc. et al: Class Action Complaint (‘Securities Fraud’)

Class Action Complaint in Kempen International Funds (MercLin Global Equity and MercLin Patrimonium), of Luxembourg, and MercLin Institutional Fund (MercLin Institutional Equity Fund DBI-RDT), of Belgium v. Syneos Health Inc., described as “a multinational clinical research organization that helps biopharmaceutical companies test and develop their products”; Alistair MacDonald, Michelle Keefe, and Jason Meggs at the U.S. District Court for the Southern District of New York.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 47

Date: October 08, 2023

Defendants/Respondents: Syneos Health Inc., Alistair MacDonald, Michelle Keefe, Jason Meggs

Plaintiffs/Applicants: Kempen International Funds, MercLin Institutional Fund

Case Number: Xx Xx Xx

Topic: Investment, Listed Securities

Allegation: Fraud

Plaintiffs/Applicants Attorneys: DiCello Levitt Gutzler, Greg Gutzler

Topics

USA

[ 1 more... ] [ top 5 ]

Keywords

Alistair MacDonald Jason Meggs Kempen International Funds Merclin Institutional Fund Michelle Keefe

Syneos Health

[ 1 more... ] [ top 5 ]

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.